2003
- 2003/09/22
- Success in developing a new method for monitoring insertion sites of introduced genes with high accuracy
- 2003/09/03
- Samsung Seoul Hospital officially announces that Korea's first Phase I clinical study of angiogenesis gene therapy, supported by Takara Bio Inc., has been completed: expected results were obtained and safety has been verified
- 2003/05/26
- Takara Bio Grants VIRxSYS License to Use RetroNectin™ for Gene Transfer Therapy
- 2003/05/19
- Basic Patent Issued in Japan for Isothermal and Chimeric Primer-Initiated Amplification of Nucleic Acids (ICAN) Method
- 2003/05/14
- Establishment of joint venture company for cancer immunotherapy business by Takara Bio Inc. and The Mizumachi Medical Group
- 2003/02/17
- Takara Bio releases New Meat Discrimination Kits Using Fast and Highly Sensitive Real Time PCR
- 2003/02/12
- Takara Bio is to collaborate with MolMed on gene therapy in Asia
- 2003/01/30
- Takara Bio Will Release FLT3/ITD Mutation Detection Set for Refractory Leukemia
